Heart Valve Repair and Replacement Decision / 心脏瓣膜修复与置换决策

Definition

Heart valve repair and replacement decision / 心脏瓣膜修复与置换决策 is the case-specific choice among preserving a patient’s valve, replacing it with a mechanical or biological prosthesis, or using a selected catheter-based approach according to valve pathology, repairability, residual-disease risk, durability, anticoagulation burden, reintervention risk, patient context, and center expertise.

Current Synthesis

The source begins with function: cardiac valves act as one-way gates, so stenosis obstructs forward flow while regurgitation permits backward flow and increases cardiac load. That mechanism does not by itself select a procedure. Disease severity, anatomy, symptoms, operative risk, likely repair quality, patient preferences and circumstances, and the experience of the treating center shape whether observation, repair, replacement, or a catheter-based option is appropriate.

Valve preservation is favored when it can produce a reliable result, but “repair at all costs” is not the synthesis. A forced repair that leaves important residual regurgitation can expose the patient to further bypass time, another operation, or early failure. Intraoperative imaging helps test the result, while surgeon and center experience affect what is technically achievable.

When replacement is necessary, mechanical and biological valves exchange different long-term burdens. The source frames mechanical valves as more durable but coupled to ongoing anticoagulation and thrombotic or bleeding-related management; biological valves may reduce long-term anticoagulation needs for selected patients but can deteriorate and require later reintervention. Neither is inherently best outside an individual clinical context.

Key Claims

• Valve stenosis and regurgitation create different flow problems, but anatomy and clinical effect must be assessed before treatment is selected.
• Durable native-valve repair is generally preferred when feasible because it preserves the patient’s own tissue.
• Repair should not be forced when the likely result leaves important residual disease or creates disproportionate repeat-procedure risk.
• Intraoperative imaging and experienced-team judgment are part of evaluating repair quality rather than assuming technical completion equals success.
• Mechanical replacement emphasizes durability while adding long-term anticoagulation and prosthesis-related management burdens.
• Biological replacement may reduce long-term anticoagulation burden for selected patients but has finite durability and possible reintervention risk.
• Catheter-based and minimally invasive options are selective routes whose suitability follows the disease and indication rather than their novelty.

Evidence

• Mechanism and selection: VOL.65 distinguishes stenosis from regurgitation and places conventional, minimally invasive, and catheter-based treatment behind specialist assessment.
• Repair-quality boundary: VOL.65 prefers repair when feasible but warns that forced repair can leave moderate or severe regurgitation, with intraoperative transesophageal imaging used to assess the result.
• Prosthesis tradeoff: VOL.65 contrasts mechanical-valve durability and anticoagulation burden with biological-valve degeneration and possible later replacement.

Counterevidence & Qualifications

The source is one edited public-education episode, not a valve guideline, comparative trial, operative assessment, or individualized recommendation. It does not establish repairability, prosthesis choice, anticoagulation strategy, transcatheter eligibility, or timing for any patient. Its statements about average biological-valve life, early anticoagulation, newer-valve durability, thrombosis, embolism, residual regurgitation, and center effects are source-scoped and may vary by valve position, device generation, age, comorbidity, anatomy, procedure, and current evidence.

What Changed

• Created a valve-specific framework separating repair feasibility from repair-at-all-costs and mechanical durability from biological reintervention risk.

Related Concepts

• Cardiac Surgery Modality Selection / 心脏外科术式选择 - access-route framework that remains subordinate to valve pathology and therapeutic objective.
• Medical Risk Management - broader comparison of untreated disease, procedural risk, medication burden, and long-term consequences.
• Medical Diagnostic Reasoning - clinical synthesis required before stenosis, regurgitation, severity, and treatment indication are established.
• Heart Failure / 心力衰竭 - possible downstream syndrome when important valve disease creates sustained pressure or volume load.